Vir Biotechnology is entering a catalyst-rich period with key clinical trial readouts from the ECLIPSE program in hepatitis delta plus updates from its T-cell engagers in oncology indications. VIR has ...

Vir and Arshad have actually known each other for over two decades. Back in 2003, a young Vir appeared in Munna Bhai M.B.B.S. as Circuit's on-screen son — affectionately nicknamed Short Circuit — in a ...

Rockstar said GTA 6 costs $79.99 across PlayStation 5 and Xbox Series X and S, confirming a $10 jump from the standard $70 we’ve seen this generation. The Ultimate Edition, meanwhile, is $20 more, ...

Forbes contributors publish independent expert analyses and insights. News and opinion about video games, television, movies and the internet. This voice experience is generated by AI. Learn more.

Superstring Capital acquired 730,548 shares of Vir Biotechnology last quarter; the estimated trade size was $5.82 million based on quarterly average prices. The quarter-end position value rose $6.55 ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Superstring Capital Management disclosed a new position in Vir Biotechnology(NASDAQ:VIR), acquiring 730,548 shares in the first quarter. The estimated transaction value was $5.82 million based on ...

Overall survival from the phase 2 trial of abiraterone, olaparib, or abiraterone + olaparib in first-line metastatic castration-resistant prostate cancer (mCRPC) with DNA repair defects (BRCAAway).

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Our latest round-up of pharma licensing deals features assets from Vir Biotech, Harbour BioMed, Unnatural Products, Genhouse, and CSL. While Vir Biotech is best known for its work on infectious ...